MarketInOut Stock Screener Log In | Sign Up
 

MediciNova Inc

TSE • Healthcare • Biotechnology • Quote as of 09/18/2026
MediciNova Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization16,932 mln
Float47.81 mln
Earnings Date11/12/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

1.33
Highly suspicious

Relative Strength

100 / 100
Top performer

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-1,168%
Severely loss-making

ROE

-25.71
Deeply negative

Business Description

MediciNova is a US-based drug development company working to create new treatments for serious conditions that currently have few or no effective options. Its two lead compounds are taken by mouth and are being tested in mid-stage clinical trials ? one targeting a range of neurological diseases, and the other addressing liver and metabolic conditions. Founded in 2000 and based in La Jolla, California, the company remains focused on advancing these treatments toward patients who need them most.

Key Fundamentals

EPS-32.42
ROE-25.71
RPS2.92
ROIC-77.78
ROA-23.77
EBITDA, mln-1,838
EV / EBITDA-3.85
EV / EBIT-3.85
Revenue, mln145
EV / Revenue49.54

Quote Details

Last 485.00
Change 100 (25.97%)
Open 458.00
Volume 1,436,200
Turnover 696,556,992
Average Volume 224,905

Financial Ratios

Pre-Tax Profit Margin-1,168
Leverage Ratio1.08
Current Ratio8.75
Price / Book1.90
Price / Tangible Book3.06
Debt / Equity0.00
Price / Sales75.79

Financial Strength

Altman Z-Score-2.09
Piotroski F-Score 4 / 9
Beneish M-Score1.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 79.63% 100 / 100   
1 Month 128% 100 / 100   
2 Months 144% 100 / 100   
6 Months 113% 99 / 100   
1 Year 144% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us